View Older Stories View More Recent Stories

Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 7, 2023 01:22AM Biotech firms target weight-loss drugs without Wegovy's side-effects
Jul 6, 2023 04:33PM Form SC 13G Talaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 6, 2023 04:31PM Form SC 13G Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 27, 2023 05:01PM Form SC 13D/A Aerovate Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 26, 2023 07:08AM Orchard Therapeutics (ORTX) Announces Second Closing of Strategic Financing, Resulting in $34 Million of Additional Capital
Jun 26, 2023 07:00AM Orchard Therapeutics Announces Second Closing of Strategic Financing, Resulting in $34 Million of Additional Capital
Jun 22, 2023 08:22AM Aeglea BioTherapeutics (AGLE) Acquires Spyre Therapeutics
Jun 22, 2023 08:17AM Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
Jun 22, 2023 07:31AM Talaris Therapeutics (TALS) and Tourmaline Bio Announce Merger Agreement
Jun 22, 2023 07:30AM Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
Jun 22, 2023 06:33AM Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
Jun 21, 2023 05:01PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 20, 2023 03:00AM Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesen as Chief Medical Officer
Jun 12, 2023 05:01PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 7, 2023 08:00AM DTx Pharma Receives FDA Orphan Drug Designation for DTx-1252 for the Treatment of Charcot-Marie-Tooth Disease Type 1A (CMT1A)
Jun 5, 2023 04:32PM Form SC 13G 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 1, 2023 08:00AM T-knife Therapeutics Presents Preclinical Data on the Anti-Tumor Activity of TK-8001 at ISCT Annual Meeting
Jun 1, 2023 07:00AM Jnana Therapeutics to Present at the Jefferies Healthcare Conference
May 31, 2023 07:00AM Jnana Therapeutics Reports Positive Topline Results from Phase 1a Clinical Study of JNT-517, a Potential First-in-Class Oral Treatment for PKU
May 30, 2023 05:01PM Form SC 13D/A Icosavax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 30, 2023 03:00AM Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline
May 25, 2023 04:03PM Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes
May 25, 2023 02:00PM Be Biopharma to Present at the Jefferies Healthcare Conference
May 24, 2023 08:00AM MBX Biosciences to Participate in Jefferies Healthcare Conference
May 24, 2023 07:00AM Jnana Therapeutics Announces Milestone Achieved Under First Collaboration with Roche
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 19, 2023 06:00AM Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells without Preconditioning in Non-Human Primates with Intact Immune Systems
May 18, 2023 06:00AM Be Biopharma Announces Oral Presentation on Precise Genome Engineering of Human B Cells to Express Diverse Therapeutic Proteins at American Society of Gene & Cell Therapy 26th Annual Meeting
May 16, 2023 07:00AM Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncoge
May 15, 2023 05:02PM Form SC 13G/A ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A DA32 Life Science Tech Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 04:18PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 11, 2023 09:00AM Adela Announces Appointment of Alan Williams as Chief Operating Officer
May 8, 2023 08:00AM MBX Biosciences to Participate in May Investor Conferences
May 3, 2023 08:00AM Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
May 2, 2023 05:35PM Scribe Therapeutics Announces Oral Presentation at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
View More Recent Stories View Older Stories